Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.3711
-0.0094-2.47%
Volume:26.95M
Turnover:9.94M
Market Cap:63.87M
PE:-0.98
High:0.3759
Open:0.3700
Low:0.3538
Close:0.3805
Loading ...

Renovaro Taps Nathen Fuentes as Finance Chief

Dow Jones
·
07 Jan

Renovaro BioSciences issues shareholder letter, provides corporate update

TIPRANKS
·
07 Jan

Renovaro BioSciences appoints Fuentes as Chief Financial Officer

TIPRANKS
·
07 Jan

Renovaro Issues Shareholder Letter and Provides Corporate Update

THOMSON REUTERS
·
07 Jan

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

THOMSON REUTERS
·
07 Jan

Renovaro Issues Shareholder Letter and Provides Corporate Update

GlobeNewswire
·
07 Jan

Press Release: Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Dow Jones
·
07 Jan

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live
·
07 Jan

Top Midday Gainers

MT Newswires Live
·
07 Jan

BUZZ-Renovaro, Predictive Oncology soar after announcing merger plans

Reuters
·
06 Jan

BRIEF-Predictive Oncology Announces Agreement To Be Acquired By Renovaro

Reuters
·
06 Jan

BRIEF-Renovaro To Acquire Predictive Oncology In All-Stock Transaction

Reuters
·
06 Jan

Renovaro Signs Letter of Intent to Acquire Predictive Oncology via All-Stock Deal

MT Newswires Live
·
06 Jan

Predictive Oncology in Deal to Be Sold to Renovaro

Dow Jones
·
06 Jan

Renovaro to acquire Predictive Oncology in all-stock transaction

TIPRANKS
·
06 Jan

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

GlobeNewswire
·
06 Jan

Predictive Oncology Inc - Renovaro Can Redeem Preferred Stock for $3.00 per Share

THOMSON REUTERS
·
06 Jan

Predictive Oncology Announces Agreement to Be Acquired by Renovaro

THOMSON REUTERS
·
06 Jan

Predictive Oncology Inc - Merger Expected to Reduce Operating Expenses by Over 30%

THOMSON REUTERS
·
06 Jan

Predictive Oncology Inc - Preferred Stock Issued in 1:1 Exchange for Predictive Oncology Common Stock

THOMSON REUTERS
·
06 Jan